Remove topic intellectual-property-patents
article thumbnail

CureVac files patent lawsuit against BioNTech over mRNA technology

Pharmaceutical Technology

CureVac has filed a patent infringement lawsuit against BioNTech in Germany over intellectual property rights of messenger ribonucleic acid (mRNA) technology. Topic sponsors are not involved in the creation of editorial content. The mRNA technology was used for the development of the Covid-19 vaccine.

article thumbnail

Moderna files lawsuits against Pfizer and BioNTech over mRNA technology

Pharmaceutical Technology

Moderna has f iled patent infringement lawsuits in the US District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany against Pfizer and BioNTech over messenger ribonucleic acid (mRNA) technology. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

Parallel Trade 2022

pharmaphorum

Policy Patent Operations. Workshop Overview: This workshop will discuss all of the main topics within parallel trade, looking back to understand the future. There will be highlights of Professor Stefan Enchelmaier’s work and case studies, focusing on re-packaging and intellectual property. Brexit Implementation.